Table 1.
Baseline characteristics (N = 98)
| Age, y | 69 (63–77) |
| Male | 69 (70.4) |
| BMI, kg/m2 | 32 (27.4–37.7) |
| History of CAD | 15 (15.3) |
| CHA2DS2-VASc score | 3 (2–4) |
| Rhythm | |
| Atrial fibrillation | 61 (62.2) |
| Atrial flutter | 37 (37.8) |
| TEE guided | 34 (34.7) |
| Successful | 92 (93.9) |
| Propofol dose, mg | 100 (68–130) |
| Midazolam dose (n = 34) | 4 (3–5) |
| Fentanyl dose (n = 34) | 75 (50–100) |
Values are median (interquartile range) or n (%).
BMI = body mass index; CAD = coronary artery disease; CHA2DS2-VASc = congestive heart failure, hypertension, age 65–74, age ≥75 years, diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism, vascular disease, sex category; TEE = transesophageal echocardiogram.